vs

Side-by-side financial comparison of Edwards Lifesciences (EW) and Victoria's Secret & Co. (VSCO). Click either name above to swap in a different company.

Edwards Lifesciences is the larger business by last-quarter revenue ($1.6B vs $1.5B, roughly 1.1× Victoria's Secret & Co.). Edwards Lifesciences runs the higher net margin — 23.1% vs -2.5%, a 25.6% gap on every dollar of revenue. On growth, Edwards Lifesciences posted the faster year-over-year revenue change (16.7% vs 9.3%). Over the past eight quarters, Edwards Lifesciences's revenue compounded faster (9.7% CAGR vs -15.9%).

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.

Victoria's Secret is an American lingerie, clothing and beauty retailer. Founded in 1977 by Stanford graduate student Roy Raymond and his wife Gaye, the company's five lingerie stores were sold to Les Wexner in 1982. Wexner rapidly expanded into American shopping malls, expanding the company into 350 stores nationally with sales of $1 billion by the early 1990s, when Victoria's Secret became the largest lingerie retailer in the United States.

EW vs VSCO — Head-to-Head

Bigger by revenue
EW
EW
1.1× larger
EW
$1.6B
$1.5B
VSCO
Growing faster (revenue YoY)
EW
EW
+7.4% gap
EW
16.7%
9.3%
VSCO
Higher net margin
EW
EW
25.6% more per $
EW
23.1%
-2.5%
VSCO
Faster 2-yr revenue CAGR
EW
EW
Annualised
EW
9.7%
-15.9%
VSCO

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
EW
EW
VSCO
VSCO
Revenue
$1.6B
$1.5B
Net Profit
$380.7M
$-37.0M
Gross Margin
78.0%
36.4%
Operating Margin
1.8%
-1.3%
Net Margin
23.1%
-2.5%
Revenue YoY
16.7%
9.3%
Net Profit YoY
6.8%
33.9%
EPS (diluted)
$0.66
$-0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EW
EW
VSCO
VSCO
Q1 26
$1.6B
Q4 25
$1.6B
$1.5B
Q3 25
$1.6B
$1.5B
Q2 25
$1.5B
$1.4B
Q1 25
$1.4B
$2.1B
Q4 24
$1.4B
$1.3B
Q3 24
$1.4B
$1.4B
Q2 24
$1.4B
$1.4B
Net Profit
EW
EW
VSCO
VSCO
Q1 26
$380.7M
Q4 25
$91.2M
$-37.0M
Q3 25
$291.1M
$16.0M
Q2 25
$333.2M
$-2.0M
Q1 25
$358.0M
$193.0M
Q4 24
$385.6M
$-56.0M
Q3 24
$3.1B
$32.0M
Q2 24
$366.3M
$-4.0M
Gross Margin
EW
EW
VSCO
VSCO
Q1 26
78.0%
Q4 25
78.1%
36.4%
Q3 25
77.8%
35.6%
Q2 25
77.5%
35.0%
Q1 25
78.7%
38.6%
Q4 24
78.9%
34.7%
Q3 24
80.6%
35.4%
Q2 24
79.9%
36.9%
Operating Margin
EW
EW
VSCO
VSCO
Q1 26
1.8%
Q4 25
9.6%
-1.3%
Q3 25
19.8%
2.8%
Q2 25
26.8%
1.5%
Q1 25
27.9%
12.8%
Q4 24
22.6%
-3.5%
Q3 24
25.9%
4.4%
Q2 24
26.8%
1.9%
Net Margin
EW
EW
VSCO
VSCO
Q1 26
23.1%
Q4 25
5.8%
-2.5%
Q3 25
18.7%
1.1%
Q2 25
21.7%
-0.1%
Q1 25
25.3%
9.2%
Q4 24
27.8%
-4.2%
Q3 24
226.7%
2.3%
Q2 24
26.7%
-0.3%
EPS (diluted)
EW
EW
VSCO
VSCO
Q1 26
$0.66
Q4 25
$0.16
$-0.46
Q3 25
$0.50
$0.20
Q2 25
$0.56
$-0.02
Q1 25
$0.61
$2.41
Q4 24
$0.65
$-0.71
Q3 24
$5.13
$0.40
Q2 24
$0.61
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EW
EW
VSCO
VSCO
Cash + ST InvestmentsLiquidity on hand
$249.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$653.0M
Total Assets
$5.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EW
EW
VSCO
VSCO
Q1 26
Q4 25
$4.2B
$249.0M
Q3 25
$3.8B
$188.0M
Q2 25
$4.1B
$138.0M
Q1 25
$3.9B
$227.0M
Q4 24
$4.0B
$161.0M
Q3 24
$4.4B
$169.0M
Q2 24
$2.0B
$105.0M
Stockholders' Equity
EW
EW
VSCO
VSCO
Q1 26
Q4 25
$10.3B
$653.0M
Q3 25
$10.2B
$680.0M
Q2 25
$10.5B
$645.0M
Q1 25
$10.1B
$640.0M
Q4 24
$10.0B
$429.0M
Q3 24
$9.5B
$472.0M
Q2 24
$7.4B
$423.0M
Total Assets
EW
EW
VSCO
VSCO
Q1 26
Q4 25
$13.7B
$5.1B
Q3 25
$13.3B
$4.8B
Q2 25
$13.5B
$4.6B
Q1 25
$13.0B
$4.5B
Q4 24
$13.1B
$4.9B
Q3 24
$13.0B
$4.6B
Q2 24
$10.1B
$4.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EW
EW
VSCO
VSCO
Operating Cash FlowLast quarter
$-180.0M
Free Cash FlowOCF − Capex
$-232.0M
FCF MarginFCF / Revenue
-15.8%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$309.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EW
EW
VSCO
VSCO
Q1 26
Q4 25
$450.9M
$-180.0M
Q3 25
$573.7M
$156.0M
Q2 25
$290.2M
$-150.0M
Q1 25
$280.4M
$674.0M
Q4 24
$-127.5M
$-248.0M
Q3 24
$351.8M
$115.0M
Q2 24
$371.5M
$-116.0M
Free Cash Flow
EW
EW
VSCO
VSCO
Q1 26
Q4 25
$353.5M
$-232.0M
Q3 25
$516.2M
$88.0M
Q2 25
$240.9M
$-193.0M
Q1 25
$224.4M
$646.0M
Q4 24
$-177.3M
$-299.0M
Q3 24
$299.9M
$55.0M
Q2 24
$286.1M
$-155.0M
FCF Margin
EW
EW
VSCO
VSCO
Q1 26
Q4 25
22.5%
-15.8%
Q3 25
33.2%
6.0%
Q2 25
15.7%
-14.3%
Q1 25
15.9%
30.7%
Q4 24
-12.8%
-22.2%
Q3 24
22.1%
3.9%
Q2 24
20.9%
-11.4%
Capex Intensity
EW
EW
VSCO
VSCO
Q1 26
Q4 25
6.2%
3.5%
Q3 25
3.7%
4.7%
Q2 25
3.2%
3.2%
Q1 25
4.0%
1.3%
Q4 24
3.6%
3.8%
Q3 24
3.8%
4.2%
Q2 24
6.2%
2.9%
Cash Conversion
EW
EW
VSCO
VSCO
Q1 26
Q4 25
4.94×
Q3 25
1.97×
9.75×
Q2 25
0.87×
Q1 25
0.78×
3.49×
Q4 24
-0.33×
Q3 24
0.11×
3.59×
Q2 24
1.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EW
EW

Segment breakdown not available.

VSCO
VSCO

Sales Channel North America Stores$778.0M53%
Sales Channel Directly To Consumer$429.0M29%
Sales Channel International$265.0M18%
Sales Channel Loyalty And Private Label Credit Card$19.0M1%

Related Comparisons